Source: Virtual Congress 2021 – COVID - 19 biomarkers



Rating:

Share or cite this content

Citations should be made in the following way:
A. REZOLA CARASUSAN (Barakaldo, Spain), L. Serrano Fernandez (Barakaldo, Spain), L. Ruiz Iturriaga (Barakaldo, Spain), E. Echevarria Guerrero (Barakaldo, Spain), B. Gonzalez Quero (Barakaldo, Spain), J. Andia Iturrate (Barakaldo, Spain), E. Garay Llorente (Barakaldo, Spain), J. Solorzano Santobeña (Barakaldo, Spain), I. Gonzalez Muñoz (Barakaldo, Spain), R. Zalacain Jorge (Barakaldo, Spain). Differences in inflammation biomarkers among COVID-19 and Non-COVID-19 pneumonia.. 659

Member's Comments

No comment yet.

Related content which might interest you: Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Dynamics of inflammation biomarkers in drug sensitive tuberculosis and pneumonia Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Role of biomarkers of systemic inflammation in the prediction of mortality and/or severe complications in community adquired pneumonia Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Studying lung inflammatory biomarkers using non-invasive methods in patients with community acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Comparison of EBC biomarkers in cystic fibrosis and bacterial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 Accuracy of inflammatory markers to distinguish between pneumonia and pulmonary embolism in acute settings Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 Relationship between the presence of hypoxemia and the inflammatory response measured by C-reactive protein in bacteremic pneumococcal pneumonia Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia. Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Relationship between markers of systemic inflammation and microstructural brain damage in COPD. Source: International Congress 2019 – From the health effects of tobacco to the epidemiology of tobacco/electronic nicotine delivery system use Year: 2019 Determination of value the biomarkers of an inflammation at atopic asthma exacerbation caused by respiratory infection Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Systemic cytokine levels in community-acquired pneumonia and their association with disease severity Source: Eur Respir J 2002; 20: 990-995 Year: 2002 Predictive systemic biomarkers of pulmonary fibrosis after COVID-19 pneumonia Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Difference of immune response in patients with severe acute pneumonia and lung abscesses Source: Eur Respir J 2004; 24: Suppl. 48, 189s Year: 2004 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 The role of serum inflammatory markers in the detection of ventilation associated pneumonia (VAP) Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Differences between local and systemic inflammatory response in patients with community acquired pneumonia (CAP) Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011